Publication Name	World Journal of Cardiology
Manuscript ID	107510
Country	Poland

Category	Cardiac & Cardiovascular Systems
Manuscript Type	Systematic Reviews
Article Title	Impact of glucagon-like peptide-1 receptor agonists on the incidence of atrial fibrillation
Manuscript Source	Invited Manuscript
All Author List	Krzysztof Glaser, Wojciech Glaser, Luca Marino, Marek Ruchala and Federico Bilotta
Funding Agency and Grant Number
Corresponding Author	Krzysztof Glaser, Doctorate Student, Department of Endocrinology, Metabolism and Internal Medicine, Poznan University of Medical Sciences, Przybyszewskiego 49, Poznan 60-355, Poland. glaser.krzysztof@gmail.com
Key Words	Glucagon-like peptide-1 receptor agonists; Antiobesity medication; Atrial fibrillation; Liraglutide; Semaglutide; Dulaglutide
Core Tip	Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are emerging as potential therapeutic agents in atrial fibrillation (AF) management due to their cardiovascular benefits and weight-reducing effects. While semaglutide has shown promise in reducing AF incidence, liraglutide and dulaglutide have yielded inconsistent results. Compared to sodium-glucose co-transporter 2 inhibitors, which demonstrate more consistent AF reduction, GLP-1 RAs require further investigation to establish their role in AF prevention and management.
Citation	Glaser K, Glaser W, Marino L, Ruchala M, Bilotta F. Impact of glucagon-like peptide-1 receptor agonists on the incidence of atrial fibrillation. World J Cardiol 2025; In press

Received	2025-03-25 05:47
Peer-Review Started	2025-03-25 05:49
To Make the First Decision
Return for Revision	2025-04-09 12:50
Revised	2025-04-21 20:15
Second Decision	2025-06-09 02:41
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2025-06-09 07:03
Articles in Press	2025-06-09 07:03
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript

ISSN	1949-8462 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com